Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,106,186
+$3,125,108 QoQ
Shares Held
334,138
+4.0% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 72%
None 28%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. NRIX ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,106,186 | 334,138 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,981,078 | 321,360 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,220,124 | 275,178 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,363,498 | 255,790 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $16,686,950 | 1,465,053 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $37,882,251 | 3,188,742 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $67,571,637 | 3,586,605 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $78,242,897 | 3,482,105 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $66,822,920 | 3,201,865 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,427,098 | 233,136 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,118,943 | 205,324 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,140,115 | 145,053 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,407,490 | 140,890 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $626,297 | 70,529 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $801,583 | 73,004 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $971,112 | 74,529 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $672,827 | 53,104 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,801,643 | 842,373 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $33,649,047 | 1,162,316 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $36,732,696 | 1,226,058 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $37,006,457 | 1,394,891 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $42,295,642 | 1,360,426 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $80,476,560 | 2,447,584 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $117,595,101 | 3,368,522 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||